Bihar Assembly Election 2025

DCGI Approves Serum Institute's Covovax Covid Vaccine For 7-11 Age Group: Report

DCGI Recommends Emergency Use Authorisation To SII's Covovax For Children Aged 7-11 Years

Govt Panel Gives Nod To Serum Institute's qHPV Vaccine For Cervical Cancer Patients Aged 9-26 Yrs

Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12

COVID Vaccine: Govt Panel Recommends Permission For Phase-3 Trial Of Covovax As Booster Dose In Adults

EXPLAINED: Biological E's Corbevax Approved For 12-18 Age Group. Here Is How The Vaccine Works

Biological E's Covid Vaccine Corbevax Gets Emergency Nod For Children Aged 12-18 Years

COVID Vaccine: Single-Dose Sputnik Light Gets DCGI Nod For Emergency Use In India

Covishield, Covaxin Granted Regular Market Approval For Use In Adult Population

Prices Of Covishield, Covaxin Likely To Be Capped At Rs 275 After Regular Market Approval

Govt Panel Recommends Regular Market Approval For Covishield And Covaxin

DCGI Gives Nod To Bharat Biotech's Intranasal Covid Vaccine For Phase 3 'Booster Dose Study'